ALKS FY 2013 Earnings — Alkermes plc Revenue & Financial Results | Market Cap Arena

ALKSAlkermes plc

$5B

FY 2013 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$576M+0.0% YoY

Gross Profit

$265M46.1% margin

Operating Income

$82M14.2% margin

Net Income

$25M4.3% margin

EPS (Diluted)

$0.18

Cash Flow

Operating Cash Flow

$127M

Free Cash Flow

$104M

Stock-Based Comp.

$41M

Balance Sheet

Total Assets

$1.5B

Total Liabilities

$518M

Stockholders' Equity

$952M

Cash & Equivalents

$97M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$576M	$576M	+0.0%
Gross Profit	$265M	$405M	-34.6%
Operating Income	$82M	$82M	+0.0%
Net Income	$25M	$25M	+0.0%